The rapid effects of estrogen: A mini-review

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 465-472

  Lokuge, Sonali ^a   Frey, Benicio N ^a,c   Foster, Jane A ^b,c   Soares, Claudio N ^a,b,c   Steiner, Meir ^a,b,c  

^a Women's Health Concerns Clinic   (Canada)

^b Brain Body Institute   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

antidepressants; BDNF; CREB; estrogen; estrogen receptor; female specific mood disorders; GPR30; reproductive cyclicity; serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESIPRAMINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUOXETINE; G PROTEIN COUPLED RECEPTOR 30; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

CLINICAL TRIAL; DEPRESSION; DRUG POTENTIATION; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; FUNCTIONAL GENOMICS; HUMAN; INTRACELLULAR SIGNALING; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PREMENSTRUAL DYSPHORIC DISORDER; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PSYCHOPHARMACOLOGY; PUERPERAL DEPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SEROTONINERGIC SYSTEM; THERAPY EFFECT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; MOOD DISORDERS; RECEPTORS, ESTROGEN; SEROTONIN; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77955985525     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833da5c3     Document Type: Review

References (101)

1. Abraham IM, Han SK, Todman MG, Korach KS, Herbison AE (2003). Estrogen receptor beta mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 23:5771-5777.
2. Abraham IM, Todman MG, Korach KS, Herbison AE (2004). Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 145:3055-3061.
3. Ahokas A, Aito M, Rimon R (2000). Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 61:166-169.
4. Balthazart J, Cornil CA, Taziaux M, Charlier TD, Baillien M, Ball GF (2006). Rapid changes in production and behavioral action of estrogens. Neuroscience 138:783-791.
5. Bethea CL, Mirkes SJ, Shively CA, Adams MR (2000). Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 47:562-576.
6. Blendy JA (2006). The role of CREB in depression and antidepressant treatment. Biol Psychiatry 59:1144-1150.
7. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI, et al. (2007). Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol 193:311-321.
8. Bulayeva NN, Gametchu B, Watson CS (2004). Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69:181-192.
9. Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F, et al. (2004). Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors. Neuroscience 127:261-267.
10. Chaban VV, Lakhter AJ, Micevych P (2004). A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 145:3788-3795.
11. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406.
12. Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. (2002). Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol. 100:435-444.
13. Cross E, Roselli CE (1999). 17 beta-estradiol rapidly facilitates chemoinvestiga-tion and mounting in castrated male rats. Am J Physiol 276:R1346-R1350.
14. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, et al. (1997). Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235:99-102.
15. Estrada-Camarena E, Fernandez-Guasti A, Lopez-Rubalcava C (2003). Anti-depressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 28:830-838.
16. Estrada-Camarena E, Rivera NM, Berlanga C, Fernandez-Guasti A (2008). Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test. Psychopharmacology (Berl) 201:351-360.
17. Figtree GA, McDonald D, Watkins H, Channon KM (2003). Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 107:120-126.
18. Filardo EJ, Thomas P (2005). GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16:362-367.
19. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
20. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI (2002). Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
21. Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R (1998). Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25:764-775.
22. Frey BN, Lord C, Soares CN (2008). Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int 14:123-128.
23. Friend KE, Ang LW, Shupnik MA (1995). Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci\USA 92:4367-4371.
24. Frye CA, Rhodes ME (2002). Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus. Brain Res 956:285-293.
25. Gibbs RB (1999). Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Res 844:20-27.
26. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996). Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:930-933.
27. Gundlah C, Lu NZ, Bethea CL (2002). Ovarian steroid regulation of monoamine oxidase-A and-B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 160:271-282.
28. Hiroi R, McDevitt RA, Neumaier JF (2006). Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry 60:288-295.
29. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A (2000). Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60:321-327.
30. Jackson A, Uphouse L (1998). Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action. Brain Res 796:299-302.
31. Jensen EV, Jacobson HI, Walf AA, Frye CA (2010). Estrogen action: a historic perspective on the implications of considering alternative approaches. Physiol Behav 99:151-162.
32. Joffe H, Petrillo LF, Viguera AC, Gottshcall H, Soares CN, Hall JE, et al. (2007). Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report. J Clin Psychiatry 68:1954-1962.
33. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, et al. (1999). Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci\USA 96:15133-15136.
34. Kelly MJ, Ronnekleiv OK (2009). Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol Cell Endocrinol 308:17-25.
35. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK (1999). Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64:64-75.
36. Klinge CM (2001). Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919.
37. Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA (2006). Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies. J Clin Psychiatry 67:1624-1632.
38. Laifenfeld D, Karry R, Grauer E, Klein E, Ben-Shachar D (2005). Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity. Neurobiol Dis 20:432-441.
39. Lee SJ, Campomanes CR, Sikat PT, Greenfield AT, Allen PB, McEwen BS (2004). Estrogen induces phosphorylation of cyclic AMP response element binding (pCREB) in primary hippocampal cells in a time-dependent manner. Neuroscience 124:549-560.
40. Levin ER (2002). Cellular functions of plasma membrane estrogen receptors. Steroids 67:471-475.
41. Li L, Haynes MP, Bender JR (2003). Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci\USA 100:4807-4812.
42. Li Q, Muma NA, van de Kar LD (1996). Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279:1035-1042.
43. Liu Y, Fowler CD, Young LJ, Yan Q, Insel TR, Wang Z (2001). Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. J Comp Neurol 433:499-514.
44. Lonze BE, Ginty DD (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
45. Lucki I (1998). The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151-162.
46. McEwen BS, Alves SE (1999). Estrogen actions in the central nervous system. Endocr Rev 20:279-307.
47. McQueen JK, Wilson H, Fink G (1997). Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res Mol Brain Res 45:13-23.
48. Mendelsohn ME (2009). Estrogen actions in the cardiovascular system. Climacteric 12 (Suppl 1):18-21.
49. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E (1996). Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300.
50. Mize AL, Alper RH (2002). Rapid uncoupling of serotonin-1A receptors in rat hippocampus by 17beta-estradiol in vitro requires protein kinases A and C. Neuroendocrinology 76:339-347.
51. Mize AL, Poisner AM, Alper RH (2001). Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73:166-174.
52. Molina-Hernandez M, Tellez-Alcantara NP, Olivera-Lopez JI, Jaramillo MT (2009). Olanzapine plus 17-beta estradiol produce antidepressant-like actions in rats forced to swim. Pharmacol Biochem Behav 93:491-497.
53. Moriarty K, Kim KH, Bender JR (2006). Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147:5557-5563.
54. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL (1992). A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131:1305-1312.
55. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, et al. (2000). Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48:854-860.
56. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
57. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372.
58. Noel SD, Keen KL, Baumann DI, Filardo EJ, Terasawa E (2009). Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol Endocrinol 23:349-359.
59. Oinonen KA, Mazmanian D (2002). To what extent do oral contraceptives influence mood and affect? J Affect Disord 70:229-240.
60. Osterlund MK, Halldin C, Hurd YL (2000). Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse 35:39-44.
61. Pappas TC, Gametchu B, Watson CS (1995). Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9:404-410.
62. Pecins-Thompson M, Bethea CL (1999). Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 89:267-277.
63. Pedram A, Razandi M, Levin ER (2006). Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2009.
64. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ (2008). Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70:165-190.
65. Raap DK, DonCarlos L, Garcia F, Muma NA, Wolf WA, Battaglia G, et al. (2000). Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology 39:1823-1832.
66. Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS (1998). Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci\USA 95:13941-13946.
67. Razandi M, Pedram A, Greene GL, Levin ER (1999). Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in chinese hamster ovary cells. Mol Endocrinol 13:307-319.
68. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER (2004). Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18:2854-2865.
69. Reif A, Lesch KP (2003). Toward a molecular architecture of personality. Behav Brain Res 139:1-20.
70. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630.
71. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR (2000). Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci\USA 97:5930-5935.
72. Russo-Neustadt A, Beard RC, Cotman CW (1999). Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21:679-682.
73. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414-420.
74. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5:97-106.
75. Sell SL, Craft RM, Seitz PK, Stutz SJ, Cunningham KA, Thomas ML (2008). Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrino-logy 33:1051-1060.
76. Sheldahl LC, Shapiro RA, Bryant DN, Koerner IP, Dorsa DM (2008). Estrogen induces rapid translocation of estrogen receptor beta, but not estrogen receptor alpha, to the neuronal plasma membrane. Neuroscience 153:751-761.
77. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF (1995). Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 38:814-818.
78. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD (1999). Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188.
79. Smith LJ, Henderson JA, Abell CW, Bethea CL (2004). Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 29:2035-2045.
80. Soares CN, Steiner M (2009). Perinatal depression: searching for specific tools for a closer look at this window. J Clin Psychiatry 70:1317-1318.
81. Soares CN, Almeida OP, Joffe H, Cohen LS (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529-534.
82. Spary EJ, Maqbool A, Batten TF (2009). Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat 38:185-196.
83. Steiner M (1992). Female-specific mood disorders. Clin Obstet Gynecol 35:599-611.
84. Steiner M, Dunn E, Born L (2003). Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74:67-83.
85. Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee MD, Van Erp E (2005). Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder. Am J Obstet Gynecol 193:352-360.
86. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE (1999). Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458.
87. Thomas P, Pang Y, Filardo EJ, Dong J (2005). Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624-632.
88. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, et al. (2004). Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychophar-macology 29:1831-1840.
89. Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, Malik AB (2004). Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci\USA 101:7699-7704.
90. Toran-Allerand CD (2005). Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol. Ann N Y Acad Sci 1052:136-144
91. Wade CB, Robinson S, Shapiro RA, Dorsa DM (2001). Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 142:2336-2342.
92. Walf AA (2010). Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues. J Neuroendocrinol 22:141-151.
93. Walf AA, Frye CA (2007). Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86:407-414.
94. Walf AA, Frye CA (2008). Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen. Steroids 73:997-1007.
95. Walf AA, Frye CA (2009a). Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model. Gend Med 6:300-311.
96. Walf AA, Frye CA (2009b). Estradiol reduces anxiety-and depression-like behavior of aged female mice. Physiol Behav 99:169-174.
97. Walf AA, Frye CA (2010). Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats. Behav Pharmacol 21:231-240.
98. Walf AA, Koonce CJ, Frye CA (2008). Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav Neurosci 122:974-981.
99. Zhou J, Zhang H, Cohen RS, Pandey SC (2005). Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures. Neuroendocrinology 81:294-310.
100. Zivadinovic D, Watson CS (2005). Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7:R130-144.
101. Zivadinovic D, Gametchu B, Watson CS (2005). Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 7:R101-R112.